- Report
- October 2025
- 196 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- October 2025
- 474 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- October 2025
- 413 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- December 2024
- 200 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Report
- September 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- September 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- September 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- September 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- April 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- April 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- January 2025
- 180 Pages
Global
From €3994EUR$4,500USD£3,483GBP
- Report
- December 2024
- 200 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Report
- May 2025
- 115 Pages
Global
From €4216EUR$4,750USD£3,676GBP
- Report
- May 2025
- 154 Pages
Global
From €4216EUR$4,750USD£3,676GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more